Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study

作者：Carina A. Rodriguez, Eva Natukunda, Renate Strehlau, Esme L Venter, Supattra Rungmaitree, Coleen K. Cunningham, Umesh Lalloo, Pope Kosalaraksa, Elizabeth Hellström, Afaaf Liberty, Eric McGrath, Meenu Kaur, Rory Leisegang, Jason T. Hindman, Vinícius Vieira, Kathryn Kersey, Mark F. Cotton, Natella Rakhmanina, Aditya H. Gaur · 发表于：The Lancet HIV · 年份：2024 · DOI：10.1016/s2352-3018(23)00327-2 · 被引用次数：13 · 研究领域：HIV/AIDS drug development and treatment、HIV-related health complications and treatments、HIV/AIDS Research and Interventions